Reverse Payment: Litigation Procedures and Strategies in 2019 Explored!
Since the Supreme Court's landmark ruling in Actavis, the number of "pay-for-delay" settlements and the use of anti-competitive agreements in the pharmaceutical industry have significantly declined. For the past years, the Federal Trade Commission (FTC) has been continuously in pursuit of challenging reverse payment settlement agreements. However, despite the remarkable developments surrounding payment settlements, new and current litigation in relation to pre-Actavis is expected to continue for the years to come.
The only way to prevent costly settlements and penalties is to ensure a complete understanding of the recent trends and developments surrounding reverse payment settlement agreements.
Join a panel of thought leaders and professionals brought together by The Knowledge Group as they provide the audience with an in-depth analysis of the current trends surrounding the reverse payment settlement agreements landscape. Speakers will also go beyond the basics and provide practical tips and strategies to avoid common risks and pitfalls.
This LIVE webcast will examine the most significant issues in the mix including:
- Reverse Payment Settlement: Pre and Post Actavis
- Significant Court Rulings
- Recent Case Decisions
- Implications to the Current Landscape
- Trends and Developments in 2019
- Remedies including damages frameworks
- What Lies Ahead
Jordy Hur, Attorney
Federal Trade Commission
- Developments in the brand-generic patent settlement cases since the Supreme Court’s Actavis decision in 2013
- Views concerning the competitive implications of a brand company’s agreements not to launch an “authorized generic” in competition with generic companies
- Findings from the brand-generic agreements filed with the FTC under the Medicare Modernization Act
Carletta Wong, Vice President
Analysis Group, Inc.
- Overview of the complicated distribution chain for pharmaceutical products, including differences for brand and generic products
- Discussion of the types of plaintiffs in reverse payment cases, and where they fit into the distribution chain
- Typical damages frameworks vs. economic harm
Who Should Attend:
- Patent Attorneys
- Patent Licensing Attorneys
- Patent Litigators
- IP Attorneys & Related Consultants
- Pharmaceutical Industry Lawyers
- Biotech/Pharma/Healthcare Attorneys & Advisors
- Drug Manufacturing Company Executives
Ms. Wong has over a decade of experience applying economic consulting expertise in a variety of litigation matters involving securities, accounting, antitrust, corporate governance, pharmaceutical reverse payments, off-label pharmaceutical marketing, and intellectual property and trade secrets. These cases have spanned a range of industries, including health care, telecommunications, entertainment media, finance, software, real estate, and manufacturing. Ms. Wong has supported experts and attorneys in many aspects of litigation, including assisting with preparation of complex expert reports by prominent academic affiliates, performing econometric and statistical analyses, preparing experts for testimony, consulting throughout the discovery process, and assisting attorneys with cross-examination of opposing experts. Ms. Wong received her M.B.A. from the MIT Sloan School of Management and her A.B. in economics from Harvard University.
Ms. Wong has over a decade of experience applying economic consulting expertise in a variety of litigation matters involving securities, …
Jordy Hur is an attorney in the Health Care Division of the Federal Trade Commission’s Bureau of Competition in Washington, D.C. She investigates alleged violations of the antitrust law by pharmaceutical companies, physicians and other health professionals, and hospitals and institutional providers. Jordy has also been involved in multiple federal court litigations challenging anticompetitive practices in the pharmaceutical industry, including reverse payment litigations.
Jordy Hur is an attorney in the Health Care Division of the Federal Trade Commission’s Bureau of Competition in Washington, …
Print and review course materials
Method Of Presentation:
General knowledge of patent/antitrust laws
NY Category of CLE Credit:
Areas of Professional Practice
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
UNLIMITED 1 Year Pass for only $199
About Analysis Group, Inc.
Analysis Group is one of the largest international economics consulting firms, with more than 950 professionals across 14 offices in North America, Europe, and Asia. Since 1981, we have provided expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune Global 500 companies, and government agencies worldwide. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional breadth and depth of expertise.
About Federal Trade Commission a
The FTC is a bipartisan federal agency with a unique dual mission to protect consumers and promote competition. For one hundred years, our collegial and consensus-driven agency has championed the interests of American consumers. As we begin our second century, the FTC is dedicated to advancing consumer interests while encouraging innovation and competition in our dynamic economy.